EAM Investors, LLC - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 16 filers reported holding CANCER GENETICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q2 2017$422,000
-12.6%
106,744
-9.4%
0.07%
-7.9%
Q1 2017$483,000
-52.5%
117,878
-9.3%
0.08%
-52.8%
Q3 2015$1,016,000
-33.0%
129,972
+0.8%
0.16%
-9.6%
Q2 2015$1,517,000
+65.6%
128,969
+185.2%
0.18%
-2.7%
Q3 2013$916,00045,2220.18%
Other shareholders
CANCER GENETICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 581,200$1,157,0001.33%
Fairbanks Capital Management, Inc. 233,170$464,0000.56%
DIKER MANAGEMENT LLC 29,815$59,0000.02%
SABBY MANAGEMENT, LLC 199,580$397,0000.02%
Sterneck Capital Management, LLC 14,750$29,0000.02%
Spot Trading L.L.C 151,900$302,0000.01%
Acrospire Investment Management LLC 3,514$7,0000.01%
EAGLE GLOBAL ADVISORS LLC 84,320$168,0000.01%
BECK MACK & OLIVER LLC 18,225$36,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 47,600$94,0000.00%
View complete list of CANCER GENETICS INC shareholders